ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa04740	Olfactory transduction	15/85	440/8135	4.255e-05	0.008681	0.008681	CALML6/OR6C2/OR13C9/OR5AU1/OR4D9/OR7G3/OR52N5/OR5I1/OR13H1/OR1B1/OR51M1/OR1G1/OR52E5/OR3A2/OR2L13	15
KEGG	hsa04060	Cytokine-cytokine receptor interaction	9/85	295/8135	0.003521	0.3591	0.3591	TNFSF18/CXCL6/BMP5/CCL19/CXCL9/IL6/GH2/IFNK/BMPR1A	9
KEGG	hsa04080	Neuroactive ligand-receptor interaction	9/85	353/8135	0.01107	0.7529	0.7529	TAAR1/MC3R/GABRR2/NPFFR2/MLN/GIP/FSHB/GPR83/GH2	9
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	4/85	100/8135	0.02039	0.8207	0.8207	CXCL6/CCL19/CXCL9/IL6	4
KEGG	hsa00053	Ascorbate and aldarate metabolism	2/85	30/8135	0.03885	0.8207	0.8207	UGT2A3/AKR1A1	2
KEGG	hsa05133	Pertussis	3/85	76/8135	0.04487	0.8207	0.8207	CALML6/CXCL6/IL6	3
KEGG	hsa00040	Pentose and glucuronate interconversions	2/85	34/8135	0.04878	0.8207	0.8207	UGT2A3/AKR1A1	2
KEGG	hsa04062	Chemokine signaling pathway	5/85	192/8135	0.05011	0.8207	0.8207	CXCL6/CRK/VAV2/CCL19/CXCL9	5
KEGG	hsa05135	Yersinia infection	4/85	137/8135	0.05482	0.8207	0.8207	CRK/CD8B/VAV2/IL6	4
KEGG	hsa05216	Thyroid cancer	2/85	37/8135	0.05677	0.8207	0.8207	RXRG/TPM3	2
KEGG	hsa04140	Autophagy - animal	4/85	141/8135	0.05972	0.8207	0.8207	RAB33B/RHEB/EIF2AK4/RAB39B	4
KEGG	hsa05410	Hypertrophic cardiomyopathy	3/85	90/8135	0.06768	0.8207	0.8207	IGF1/IL6/TPM3	3
KEGG	hsa04015	Rap1 signaling pathway	5/85	210/8135	0.06831	0.8207	0.8207	CALML6/CRK/IGF1/FGF5/VAV2	5
KEGG	hsa05332	Graft-versus-host disease	2/85	42/8135	0.071	0.8207	0.8207	HLA-DRB1/IL6	2
KEGG	hsa05168	Herpes simplex virus 1 infection	9/85	495/8135	0.07247	0.8207	0.8207	ZNF670/RHEB/EIF2AK4/ZNF79/ZNF200/HLA-DRB1/ZNF169/IL6/ZNF555	9
KEGG	hsa05323	Rheumatoid arthritis	3/85	93/8135	0.07314	0.8207	0.8207	CXCL6/HLA-DRB1/IL6	3
KEGG	hsa05417	Lipid and atherosclerosis	5/85	215/8135	0.07394	0.8207	0.8207	CALML6/RXRG/VAV2/LBP/IL6	5
KEGG	hsa04640	Hematopoietic cell lineage	3/85	99/8135	0.08463	0.8207	0.8207	CD8B/HLA-DRB1/IL6	3
KEGG	hsa04630	JAK-STAT signaling pathway	4/85	162/8135	0.0891	0.8207	0.8207	IL22RA2/IL6/GH2/IFNK	4
KEGG	hsa00565	Ether lipid metabolism	2/85	49/8135	0.0926	0.8207	0.8207	GDPD3/PLA2G10	2
KEGG	hsa04672	Intestinal immune network for IgA production	2/85	49/8135	0.0926	0.8207	0.8207	HLA-DRB1/IL6	2
KEGG	hsa04620	Toll-like receptor signaling pathway	3/85	104/8135	0.09477	0.8207	0.8207	CXCL9/LBP/IL6	3
KEGG	hsa04913	Ovarian steroidogenesis	2/85	51/8135	0.09909	0.8207	0.8207	IGF1/FSHB	2
KEGG	hsa00600	Sphingolipid metabolism	2/85	52/8135	0.1024	0.8207	0.8207	ACER2/B4GALT6	2
KEGG	hsa04659	Th17 cell differentiation	3/85	108/8135	0.1032	0.8207	0.8207	RXRG/HLA-DRB1/IL6	3
KEGG	hsa05152	Tuberculosis	4/85	180/8135	0.1189	0.8207	0.8207	CALML6/HLA-DRB1/LBP/IL6	4
KEGG	hsa04935	Growth hormone synthesis, secretion and action	3/85	119/8135	0.1279	0.8207	0.8207	CRK/IGF1/GH2	3
KEGG	hsa05321	Inflammatory bowel disease	2/85	65/8135	0.1475	0.8207	0.8207	HLA-DRB1/IL6	2
KEGG	hsa04510	Focal adhesion	4/85	201/8135	0.1583	0.8207	0.8207	CRK/CAV2/IGF1/VAV2	4
KEGG	hsa00830	Retinol metabolism	2/85	68/8135	0.1585	0.8207	0.8207	RETSAT/UGT2A3	2
KEGG	hsa04910	Insulin signaling pathway	3/85	137/8135	0.1722	0.8207	0.8207	CALML6/CRK/RHEB	3
KEGG	hsa05218	Melanoma	2/85	72/8135	0.1733	0.8207	0.8207	IGF1/FGF5	2
KEGG	hsa05162	Measles	3/85	139/8135	0.1774	0.8207	0.8207	EIF2AK4/MX1/IL6	3
KEGG	hsa05418	Fluid shear stress and atherosclerosis	3/85	139/8135	0.1774	0.8207	0.8207	CALML6/CAV2/BMPR1A	3
KEGG	hsa00531	Glycosaminoglycan degradation	1/85	19/8135	0.1811	0.8207	0.8207	ARSB	1
KEGG	hsa03320	PPAR signaling pathway	2/85	75/8135	0.1846	0.8207	0.8207	RXRG/FABP4	2
KEGG	hsa05214	Glioma	2/85	75/8135	0.1846	0.8207	0.8207	CALML6/IGF1	2
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	3/85	143/8135	0.1879	0.8207	0.8207	IGF1/HAND1/BMPR1A	3
KEGG	hsa00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1/85	20/8135	0.1897	0.8207	0.8207	UST	1
KEGG	hsa05100	Bacterial invasion of epithelial cells	2/85	77/8135	0.1921	0.8207	0.8207	CRK/CAV2	2
KEGG	hsa04612	Antigen processing and presentation	2/85	78/8135	0.1959	0.8207	0.8207	CD8B/HLA-DRB1	2
KEGG	hsa01521	EGFR tyrosine kinase inhibitor resistance	2/85	79/8135	0.1997	0.8207	0.8207	IGF1/IL6	2
KEGG	hsa04024	cAMP signaling pathway	4/85	221/8135	0.1998	0.8207	0.8207	CALML6/VAV2/GIP/FSHB	4
KEGG	hsa04514	Cell adhesion molecules	3/85	149/8135	0.2039	0.8207	0.8207	CD8B/HLA-DRB1/NLGN1	3
KEGG	hsa05163	Human cytomegalovirus infection	4/85	225/8135	0.2084	0.8207	0.8207	CALML6/CRK/RHEB/IL6	4
KEGG	hsa04218	Cellular senescence	3/85	156/8135	0.2229	0.8207	0.8207	CALML6/RHEB/IL6	3
KEGG	hsa04014	Ras signaling pathway	4/85	232/8135	0.2239	0.8207	0.8207	CALML6/IGF1/FGF5/PLA2G10	4
KEGG	hsa05171	Coronavirus disease - COVID-19	4/85	232/8135	0.2239	0.8207	0.8207	RPL36AL/MX1/IL6/RPL10L	4
KEGG	hsa04742	Taste transduction	2/85	86/8135	0.2266	0.8207	0.8207	TAS2R20/HTR3C	2
KEGG	hsa00592	alpha-Linolenic acid metabolism	1/85	25/8135	0.2312	0.8207	0.8207	PLA2G10	1
KEGG	hsa04211	Longevity regulating pathway	2/85	89/8135	0.2382	0.8207	0.8207	RHEB/IGF1	2
KEGG	hsa04950	Maturity onset diabetes of the young	1/85	26/8135	0.2393	0.8207	0.8207	FOXA3	1
KEGG	hsa04912	GnRH signaling pathway	2/85	93/8135	0.2537	0.8207	0.8207	CALML6/FSHB	2
KEGG	hsa04970	Salivary secretion	2/85	93/8135	0.2537	0.8207	0.8207	PRH2/CALML6	2
KEGG	hsa04350	TGF-beta signaling pathway	2/85	94/8135	0.2576	0.8207	0.8207	BMP5/BMPR1A	2
KEGG	hsa04657	IL-17 signaling pathway	2/85	94/8135	0.2576	0.8207	0.8207	CXCL6/IL6	2
KEGG	hsa00591	Linoleic acid metabolism	1/85	29/8135	0.263	0.8207	0.8207	PLA2G10	1
KEGG	hsa04744	Phototransduction	1/85	29/8135	0.263	0.8207	0.8207	CALML6	1
KEGG	hsa05164	Influenza A	3/85	171/8135	0.2649	0.8207	0.8207	HLA-DRB1/MX1/IL6	3
KEGG	hsa05414	Dilated cardiomyopathy	2/85	96/8135	0.2654	0.8207	0.8207	IGF1/TPM3	2
KEGG	hsa04666	Fc gamma R-mediated phagocytosis	2/85	97/8135	0.2692	0.8207	0.8207	CRK/VAV2	2
KEGG	hsa01523	Antifolate resistance	1/85	30/8135	0.2707	0.8207	0.8207	IL6	1
KEGG	hsa04750	Inflammatory mediator regulation of TRP channels	2/85	98/8135	0.2731	0.8207	0.8207	CALML6/IGF1	2
KEGG	hsa05231	Choline metabolism in cancer	2/85	98/8135	0.2731	0.8207	0.8207	RHEB/SLC22A5	2
KEGG	hsa05310	Asthma	1/85	31/8135	0.2784	0.8207	0.8207	HLA-DRB1	1
KEGG	hsa04064	NF-kappa B signaling pathway	2/85	104/8135	0.2964	0.8207	0.8207	CCL19/LBP	2
KEGG	hsa04625	C-type lectin receptor signaling pathway	2/85	104/8135	0.2964	0.8207	0.8207	CALML6/IL6	2
KEGG	hsa04660	T cell receptor signaling pathway	2/85	104/8135	0.2964	0.8207	0.8207	CD8B/VAV2	2
KEGG	hsa04928	Parathyroid hormone synthesis, secretion and action	2/85	106/8135	0.3042	0.8207	0.8207	RXRG/TRPV5	2
KEGG	hsa04151	PI3K-Akt signaling pathway	5/85	354/8135	0.3109	0.8207	0.8207	RHEB/IGF1/FGF5/IL6/GH2	5
KEGG	hsa00350	Tyrosine metabolism	1/85	36/8135	0.3154	0.8207	0.8207	PNMT	1
KEGG	hsa00512	Mucin type O-glycan biosynthesis	1/85	36/8135	0.3154	0.8207	0.8207	GCNT1	1
KEGG	hsa03030	DNA replication	1/85	36/8135	0.3154	0.8207	0.8207	RNASEH1	1
KEGG	hsa04066	HIF-1 signaling pathway	2/85	109/8135	0.3158	0.8207	0.8207	IGF1/IL6	2
KEGG	hsa04960	Aldosterone-regulated sodium reabsorption	1/85	37/8135	0.3226	0.8207	0.8207	IGF1	1
KEGG	hsa05143	African trypanosomiasis	1/85	37/8135	0.3226	0.8207	0.8207	IL6	1
KEGG	hsa04668	TNF signaling pathway	2/85	112/8135	0.3273	0.8207	0.8207	CXCL6/IL6	2
KEGG	hsa05202	Transcriptional misregulation in cancer	3/85	193/8135	0.3278	0.8207	0.8207	RXRG/IGF1/IL6	3
KEGG	hsa05330	Allograft rejection	1/85	38/8135	0.3297	0.8207	0.8207	HLA-DRB1	1
KEGG	hsa05340	Primary immunodeficiency	1/85	38/8135	0.3297	0.8207	0.8207	CD8B	1
KEGG	hsa05033	Nicotine addiction	1/85	40/8135	0.3437	0.8207	0.8207	GABRR2	1
KEGG	hsa04722	Neurotrophin signaling pathway	2/85	119/8135	0.3541	0.8207	0.8207	CALML6/CRK	2
KEGG	hsa04152	AMPK signaling pathway	2/85	120/8135	0.3579	0.8207	0.8207	RHEB/IGF1	2
KEGG	hsa04919	Thyroid hormone signaling pathway	2/85	121/8135	0.3616	0.8207	0.8207	RXRG/RHEB	2
KEGG	hsa05205	Proteoglycans in cancer	3/85	205/8135	0.3623	0.8207	0.8207	CAV2/IGF1/VAV2	3
KEGG	hsa00860	Porphyrin metabolism	1/85	43/8135	0.3642	0.8207	0.8207	UGT2A3	1
KEGG	hsa04940	Type I diabetes mellitus	1/85	43/8135	0.3642	0.8207	0.8207	HLA-DRB1	1
KEGG	hsa04975	Fat digestion and absorption	1/85	43/8135	0.3642	0.8207	0.8207	PLA2G10	1
KEGG	hsa03022	Basal transcription factors	1/85	45/8135	0.3775	0.8207	0.8207	TAF13	1
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	3/85	212/8135	0.3824	0.8207	0.8207	RXRG/FGF5/UGT2A3	3
KEGG	hsa00620	Pyruvate metabolism	1/85	47/8135	0.3905	0.8207	0.8207	AKR1A1	1
KEGG	hsa04068	FoxO signaling pathway	2/85	131/8135	0.399	0.8207	0.8207	IGF1/IL6	2
KEGG	hsa04114	Oocyte meiosis	2/85	131/8135	0.399	0.8207	0.8207	CALML6/IGF1	2
KEGG	hsa04810	Regulation of actin cytoskeleton	3/85	218/8135	0.3994	0.8207	0.8207	CRK/FGF5/VAV2	3
KEGG	hsa04979	Cholesterol metabolism	1/85	50/8135	0.4095	0.8207	0.8207	CETP	1
KEGG	hsa05144	Malaria	1/85	50/8135	0.4095	0.8207	0.8207	IL6	1
KEGG	hsa04270	Vascular smooth muscle contraction	2/85	134/8135	0.4101	0.8207	0.8207	CALML6/PLA2G10	2
KEGG	hsa00330	Arginine and proline metabolism	1/85	51/8135	0.4157	0.8207	0.8207	P4HA2	1
KEGG	hsa04961	Endocrine and other factor-regulated calcium reabsorption	1/85	53/8135	0.4279	0.8207	0.8207	TRPV5	1
KEGG	hsa05320	Autoimmune thyroid disease	1/85	53/8135	0.4279	0.8207	0.8207	HLA-DRB1	1
KEGG	hsa04936	Alcoholic liver disease	2/85	142/8135	0.439	0.8207	0.8207	LBP/IL6	2
KEGG	hsa04923	Regulation of lipolysis in adipocytes	1/85	56/8135	0.4458	0.8207	0.8207	FABP4	1
KEGG	hsa05134	Legionellosis	1/85	57/8135	0.4516	0.8207	0.8207	IL6	1
KEGG	hsa05224	Breast cancer	2/85	147/8135	0.4567	0.8207	0.8207	IGF1/FGF5	2
KEGG	hsa05226	Gastric cancer	2/85	149/8135	0.4636	0.8207	0.8207	RXRG/FGF5	2
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	2/85	150/8135	0.4671	0.8207	0.8207	CALML6/TPM3	2
KEGG	hsa04730	Long-term depression	1/85	60/8135	0.4688	0.8207	0.8207	IGF1	1
KEGG	hsa05416	Viral myocarditis	1/85	60/8135	0.4688	0.8207	0.8207	HLA-DRB1	1
KEGG	hsa00140	Steroid hormone biosynthesis	1/85	61/8135	0.4743	0.8207	0.8207	UGT2A3	1
KEGG	hsa00561	Glycerolipid metabolism	1/85	61/8135	0.4743	0.8207	0.8207	AKR1A1	1
KEGG	hsa00590	Arachidonic acid metabolism	1/85	61/8135	0.4743	0.8207	0.8207	PLA2G10	1
KEGG	hsa01240	Biosynthesis of cofactors	2/85	153/8135	0.4775	0.8207	0.8207	UGT2A3/AKR1A1	2
KEGG	hsa04213	Longevity regulating pathway - multiple species	1/85	62/8135	0.4799	0.8207	0.8207	IGF1	1
KEGG	hsa03250	Viral life cycle - HIV-1	1/85	63/8135	0.4854	0.8207	0.8207	MX1	1
KEGG	hsa04623	Cytosolic DNA-sensing pathway	1/85	63/8135	0.4854	0.8207	0.8207	IL6	1
KEGG	hsa04150	mTOR signaling pathway	2/85	156/8135	0.4877	0.8207	0.8207	RHEB/IGF1	2
KEGG	hsa04390	Hippo signaling pathway	2/85	157/8135	0.4911	0.8207	0.8207	BMP5/BMPR1A	2
KEGG	hsa05160	Hepatitis C	2/85	157/8135	0.4911	0.8207	0.8207	EIF2AK4/MX1	2
KEGG	hsa03010	Ribosome	2/85	158/8135	0.4944	0.8207	0.8207	RPL36AL/RPL10L	2
KEGG	hsa00010	Glycolysis / Gluconeogenesis	1/85	67/8135	0.5067	0.8207	0.8207	AKR1A1	1
KEGG	hsa04720	Long-term potentiation	1/85	67/8135	0.5067	0.8207	0.8207	CALML6	1
KEGG	hsa04664	Fc epsilon RI signaling pathway	1/85	68/8135	0.5119	0.8207	0.8207	VAV2	1
KEGG	hsa04920	Adipocytokine signaling pathway	1/85	69/8135	0.517	0.8207	0.8207	RXRG	1
KEGG	hsa04924	Renin secretion	1/85	69/8135	0.517	0.8207	0.8207	CALML6	1
KEGG	hsa05031	Amphetamine addiction	1/85	69/8135	0.517	0.8207	0.8207	CALML6	1
KEGG	hsa05204	Chemical carcinogenesis - DNA adducts	1/85	69/8135	0.517	0.8207	0.8207	UGT2A3	1
KEGG	hsa05211	Renal cell carcinoma	1/85	69/8135	0.517	0.8207	0.8207	CRK	1
KEGG	hsa04622	RIG-I-like receptor signaling pathway	1/85	70/8135	0.5221	0.8207	0.8207	IFNK	1
KEGG	hsa00982	Drug metabolism - cytochrome P450	1/85	72/8135	0.5321	0.8207	0.8207	UGT2A3	1
KEGG	hsa05223	Non-small cell lung cancer	1/85	72/8135	0.5321	0.8207	0.8207	RXRG	1
KEGG	hsa04115	p53 signaling pathway	1/85	73/8135	0.5371	0.8207	0.8207	IGF1	1
KEGG	hsa04971	Gastric acid secretion	1/85	76/8135	0.5516	0.8207	0.8207	CALML6	1
KEGG	hsa05220	Chronic myeloid leukemia	1/85	76/8135	0.5516	0.8207	0.8207	CRK	1
KEGG	hsa05140	Leishmaniasis	1/85	77/8135	0.5563	0.8207	0.8207	HLA-DRB1	1
KEGG	hsa00980	Metabolism of xenobiotics by cytochrome P450	1/85	78/8135	0.561	0.8207	0.8207	UGT2A3	1
KEGG	hsa00983	Drug metabolism - other enzymes	1/85	80/8135	0.5702	0.8207	0.8207	UGT2A3	1
KEGG	hsa04662	B cell receptor signaling pathway	1/85	82/8135	0.5792	0.8207	0.8207	VAV2	1
KEGG	hsa04012	ErbB signaling pathway	1/85	85/8135	0.5924	0.8207	0.8207	CRK	1
KEGG	hsa04610	Complement and coagulation cascades	1/85	85/8135	0.5924	0.8207	0.8207	CFHR2	1
KEGG	hsa04911	Insulin secretion	1/85	86/8135	0.5967	0.8207	0.8207	GIP	1
KEGG	hsa04010	MAPK signaling pathway	3/85	294/8135	0.5983	0.8207	0.8207	CRK/IGF1/FGF5	3
KEGG	hsa04260	Cardiac muscle contraction	1/85	87/8135	0.601	0.8207	0.8207	TPM3	1
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	2/85	194/8135	0.606	0.8207	0.8207	CALML6/IL6	2
KEGG	hsa04727	GABAergic synapse	1/85	89/8135	0.6094	0.8207	0.8207	GABRR2	1
KEGG	hsa04976	Bile secretion	1/85	89/8135	0.6094	0.8207	0.8207	UGT2A3	1
KEGG	hsa05032	Morphine addiction	1/85	91/8135	0.6176	0.8207	0.8207	GABRR2	1
KEGG	hsa04658	Th1 and Th2 cell differentiation	1/85	92/8135	0.6216	0.8207	0.8207	HLA-DRB1	1
KEGG	hsa05222	Small cell lung cancer	1/85	92/8135	0.6216	0.8207	0.8207	RXRG	1
KEGG	hsa05169	Epstein-Barr virus infection	2/85	202/8135	0.6282	0.8207	0.8207	HLA-DRB1/IL6	2
KEGG	hsa05150	Staphylococcus aureus infection	1/85	96/8135	0.6373	0.8207	0.8207	HLA-DRB1	1
KEGG	hsa03015	mRNA surveillance pathway	1/85	97/8135	0.6412	0.8207	0.8207	RNPS1	1
KEGG	hsa04070	Phosphatidylinositol signaling system	1/85	97/8135	0.6412	0.8207	0.8207	CALML6	1
KEGG	hsa04713	Circadian entrainment	1/85	97/8135	0.6412	0.8207	0.8207	CALML6	1
KEGG	hsa05215	Prostate cancer	1/85	97/8135	0.6412	0.8207	0.8207	IGF1	1
KEGG	hsa00564	Glycerophospholipid metabolism	1/85	98/8135	0.645	0.8207	0.8207	PLA2G10	1
KEGG	hsa01522	Endocrine resistance	1/85	98/8135	0.645	0.8207	0.8207	IGF1	1
KEGG	hsa04925	Aldosterone synthesis and secretion	1/85	98/8135	0.645	0.8207	0.8207	CALML6	1
KEGG	hsa04933	AGE-RAGE signaling pathway in diabetic complications	1/85	100/8135	0.6524	0.8207	0.8207	IL6	1
KEGG	hsa05170	Human immunodeficiency virus 1 infection	2/85	212/8135	0.6545	0.8207	0.8207	CALML6/CRK	2
KEGG	hsa04916	Melanogenesis	1/85	101/8135	0.6561	0.8207	0.8207	CALML6	1
KEGG	hsa04914	Progesterone-mediated oocyte maturation	1/85	102/8135	0.6598	0.8207	0.8207	IGF1	1
KEGG	hsa04972	Pancreatic secretion	1/85	102/8135	0.6598	0.8207	0.8207	PLA2G10	1
KEGG	hsa05142	Chagas disease	1/85	102/8135	0.6598	0.8207	0.8207	IL6	1
KEGG	hsa05146	Amoebiasis	1/85	102/8135	0.6598	0.8207	0.8207	IL6	1
KEGG	hsa04922	Glucagon signaling pathway	1/85	107/8135	0.6774	0.8218	0.8218	CALML6	1
KEGG	hsa05165	Human papillomavirus infection	3/85	331/8135	0.6785	0.8218	0.8218	RHEB/OASL/MX1	3
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	2/85	222/8135	0.6794	0.8218	0.8218	HLA-DRB1/IL6	2
KEGG	hsa03013	Nucleocytoplasmic transport	1/85	108/8135	0.6808	0.8218	0.8218	RNPS1	1
KEGG	hsa04931	Insulin resistance	1/85	108/8135	0.6808	0.8218	0.8218	IL6	1
KEGG	hsa05145	Toxoplasmosis	1/85	112/8135	0.6941	0.8298	0.8298	HLA-DRB1	1
KEGG	hsa04670	Leukocyte transendothelial migration	1/85	114/8135	0.7006	0.8298	0.8298	VAV2	1
KEGG	hsa04714	Thermogenesis	2/85	232/8135	0.7028	0.8298	0.8298	RHEB/ACTL6B	2
KEGG	hsa04726	Serotonergic synapse	1/85	115/8135	0.7037	0.8298	0.8298	HTR3C	1
KEGG	hsa04071	Sphingolipid signaling pathway	1/85	119/8135	0.7161	0.8396	0.8396	ACER2	1
KEGG	hsa04020	Calcium signaling pathway	2/85	240/8135	0.7205	0.8399	0.8399	CALML6/FGF5	2
KEGG	hsa04650	Natural killer cell mediated cytotoxicity	1/85	131/8135	0.7502	0.8628	0.8628	VAV2	1
KEGG	hsa04142	Lysosome	1/85	132/8135	0.7529	0.8628	0.8628	ARSB	1
KEGG	hsa04728	Dopaminergic synapse	1/85	132/8135	0.7529	0.8628	0.8628	CALML6	1
KEGG	hsa05322	Systemic lupus erythematosus	1/85	136/8135	0.7632	0.8686	0.8686	HLA-DRB1	1
KEGG	hsa04915	Estrogen signaling pathway	1/85	138/8135	0.7682	0.8686	0.8686	CALML6	1
KEGG	hsa04371	Apelin signaling pathway	1/85	139/8135	0.7707	0.8686	0.8686	CALML6	1
KEGG	hsa05020	Prion disease	2/85	273/8135	0.7845	0.8778	0.8778	CAV2/IL6	2
KEGG	hsa04072	Phospholipase D signaling pathway	1/85	148/8135	0.7917	0.8778	0.8778	RHEB	1
KEGG	hsa04723	Retrograde endocannabinoid signaling	1/85	148/8135	0.7917	0.8778	0.8778	GABRR2	1
KEGG	hsa04145	Phagosome	1/85	152/8135	0.8004	0.8801	0.8801	HLA-DRB1	1
KEGG	hsa04921	Oxytocin signaling pathway	1/85	154/8135	0.8047	0.8801	0.8801	CALML6	1
KEGG	hsa04932	Non-alcoholic fatty liver disease	1/85	155/8135	0.8067	0.8801	0.8801	IL6	1
KEGG	hsa05161	Hepatitis B	1/85	162/8135	0.8207	0.8906	0.8906	IL6	1
KEGG	hsa04022	cGMP-PKG signaling pathway	1/85	167/8135	0.8301	0.8932	0.8932	CALML6	1
KEGG	hsa05225	Hepatocellular carcinoma	1/85	168/8135	0.8319	0.8932	0.8932	ACTL6B	1
KEGG	hsa04141	Protein processing in endoplasmic reticulum	1/85	171/8135	0.8372	0.8933	0.8933	EIF2AK4	1
KEGG	hsa05206	MicroRNAs in cancer	2/85	310/8135	0.8408	0.8933	0.8933	CRK/MIR137	2
KEGG	hsa04360	Axon guidance	1/85	182/8135	0.8553	0.9027	0.9027	NTN4	1
KEGG	hsa04621	NOD-like receptor signaling pathway	1/85	184/8135	0.8584	0.9027	0.9027	IL6	1
KEGG	hsa05034	Alcoholism	1/85	187/8135	0.8629	0.9027	0.9027	CALML6	1
KEGG	hsa05130	Pathogenic Escherichia coli infection	1/85	197/8135	0.8769	0.9127	0.9127	IL6	1
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	3/85	476/8135	0.8819	0.9133	0.9133	CALML6/RAB39B/IL6	3
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	1/85	223/8135	0.907	0.9345	0.9345	AKR1A1	1
KEGG	hsa05010	Alzheimer disease	2/85	384/8135	0.9156	0.9386	0.9386	CALML6/IL6	2
KEGG	hsa05131	Shigellosis	1/85	247/8135	0.9283	0.9405	0.9405	CRK	1
KEGG	hsa05132	Salmonella infection	1/85	249/8135	0.9298	0.9405	0.9405	IL6	1
KEGG	hsa04144	Endocytosis	1/85	251/8135	0.9313	0.9405	0.9405	CAV2	1
KEGG	hsa05012	Parkinson disease	1/85	266/8135	0.9416	0.9463	0.9463	CALML6	1
KEGG	hsa05014	Amyotrophic lateral sclerosis	1/85	364/8135	0.98	0.98	0.98	RAB39B	1